Taylor et al., 2006 - Google Patents
Effects of probiotic supplementation for the first 6 months of life on allergen‐and vaccine‐specific immune responsesTaylor et al., 2006
- Document ID
- 12432605682633053546
- Author
- Taylor A
- Hale J
- Wiltschut J
- Lehmann H
- Dunstan J
- Prescott S
- Publication year
- Publication venue
- Clinical & Experimental Allergy
External Links
Snippet
Background A reduction in microbial burden during infancy when allergen‐specific memory is evolving has become a prominent explanation for the allergy epidemic. Objective We sought to determine whether probiotic dietary supplementation in the first 6 months of life …
- 230000000529 probiotic 0 title abstract description 89
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Taylor et al. | Effects of probiotic supplementation for the first 6 months of life on allergen‐and vaccine‐specific immune responses | |
| Prescott et al. | Early markers of allergic disease in a primary prevention study using probiotics: 2.5‐year follow‐up phase | |
| Holscher et al. | Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula‐fed infants: a randomized, double‐blind, controlled trial | |
| Wang et al. | Children with atopic dermatitis show clinical improvement after Lactobacillus exposure | |
| Boyle et al. | Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial | |
| Forsberg et al. | Pre‐and probiotics for allergy prevention: time to revisit recommendations? | |
| Ly et al. | Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? | |
| Prescott et al. | Clinical effects of probiotics are associated with increased interferon‐γ responses in very young children with atopic dermatitis | |
| Murata et al. | Effects of paraprobiotic Lactobacillus paracasei MCC1849 supplementation on symptoms of the common cold and mood states in healthy adults | |
| Sanctuary et al. | Pilot study of probiotic/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms | |
| Dzidic et al. | Oral microbiota maturation during the first 7 years of life in relation to allergy development | |
| West et al. | Probiotics during weaning reduce the incidence of eczema | |
| Guillemard et al. | Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial | |
| Pu et al. | Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial | |
| Mortaz et al. | Probiotics in the management of lung diseases | |
| Schmidt et al. | Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial | |
| Fujimura et al. | Role of the gut microbiota in defining human health | |
| Wickens et al. | Early supplementation with Lactobacillus rhamnosus HN 001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? | |
| Shadid et al. | Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study | |
| Ou et al. | Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double‐blind, placebo‐controlled trial | |
| Zuccotti et al. | Probiotics for prevention of atopic diseases in infants: systematic review and meta‐analysis | |
| West et al. | Bugging allergy; role of pre-, pro-and synbiotics in allergy prevention | |
| Kalliomäki et al. | Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial | |
| West et al. | Probiotics in primary prevention of allergic disease–follow‐up at 8–9 years of age | |
| Kukkonen et al. | Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial |